Immediate Impact
1 by Nobel laureates 1 from Science/Nature 65 standout
Citing Papers
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
2023 Standout
Bacteria in cancer initiation, promotion and progression
2023 Standout
Works of Tulio E. Rodriguez being referenced
Clostridium difficileInfection and Limitations of Markers for Severity in Patients with Hematologic Malignancy
2012
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tulio E. Rodriguez | 205 | 218 | 75 | 288 | 53 | 699 | |
| Paul‐Gerhardt Schlegel | 166 | 208 | 145 | 164 | 35 | 739 | |
| Eiichi Ohtsuka | 196 | 292 | 48 | 382 | 51 | 753 | |
| Verena Wiegering | 238 | 113 | 56 | 162 | 58 | 768 | |
| Kenjiro Kamezaki | 181 | 270 | 72 | 244 | 46 | 747 | |
| Walter Barberi | 176 | 213 | 46 | 133 | 34 | 603 | |
| T Matsuyama | 326 | 222 | 33 | 195 | 32 | 675 | |
| B. Catteau | 128 | 107 | 107 | 222 | 49 | 689 | |
| Étienne Daguindau | 216 | 191 | 134 | 209 | 54 | 786 | |
| Daniela Caldera | 199 | 143 | 44 | 299 | 29 | 687 | |
| Y Onozawa | 267 | 149 | 80 | 158 | 53 | 641 |
All Works
Login with ORCID to disown or claim papers
Loading papers...